7月15日，复星医药（600196/02196）发布公告，控股股东复星高科技将其持有的4700万股办理质押，占其所持股份的4.89%及公司总股本的1.76%。 截至公告披露日，复星高科技累计质押股份为5.92亿股，占其所持股份的61.60%及公司总股本的22.18%。 2026年一季度，复星医药实现收入100.73亿元，归母净利润8.71亿元。（文章来源：财中社）
Source Link7月15日，复星医药（600196/02196）发布公告，控股股东复星高科技将其持有的4700万股办理质押，占其所持股份的4.89%及公司总股本的1.76%。 截至公告披露日，复星高科技累计质押股份为5.92亿股，占其所持股份的61.60%及公司总股本的22.18%。 2026年一季度，复星医药实现收入100.73亿元，归母净利润8.71亿元。（文章来源：财中社）
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.